Display options
Share it on

Biol Mood Anxiety Disord. 2011 Nov 07;1(1):10. doi: 10.1186/2045-5380-1-10.

Facial emotion processing in major depression: a systematic review of neuroimaging findings.

Biology of mood & anxiety disorders

Anja Stuhrmann, Thomas Suslow, Udo Dannlowski

Affiliations

  1. University of Münster, Department of Psychiatry, Albert-Schweitzer-Campus 1, Building, A9, 48149 Münster, Germany. [email protected].

PMID: 22738433 PMCID: PMC3384264 DOI: 10.1186/2045-5380-1-10

Abstract

BACKGROUND: Cognitive models of depression suggest that major depression is characterized by biased facial emotion processing, making facial stimuli particularly valuable for neuroimaging research on the neurobiological correlates of depression. The present review provides an overview of functional neuroimaging studies on abnormal facial emotion processing in major depression. Our main objective was to describe neurobiological differences between depressed patients with major depressive disorder (MDD) and healthy controls (HCs) regarding brain responsiveness to facial expressions and, furthermore, to delineate altered neural activation patterns associated with mood-congruent processing bias and to integrate these data with recent functional connectivity results. We further discuss methodological aspects potentially explaining the heterogeneity of results.

METHODS: A Medline search was performed up to August 2011 in order to identify studies on emotional face processing in acutely depressed patients compared with HCs. A total of 25 studies using functional magnetic resonance imaging were reviewed.

RESULTS: The analysis of neural activation data showed abnormalities in MDD patients in a common face processing network, pointing to mood-congruent processing bias (hyperactivation to negative and hypoactivation to positive stimuli) particularly in the amygdala, insula, parahippocampal gyrus, fusiform face area, and putamen. Furthermore, abnormal activation patterns were repeatedly found in parts of the cingulate gyrus and the orbitofrontal cortex, which are extended by investigations implementing functional connectivity analysis. However, despite several converging findings, some inconsistencies are observed, particularly in prefrontal areas, probably caused by heterogeneities in paradigms and patient samples.

CONCLUSIONS: Further studies in remitted patients and high-risk samples are required to discern whether the described abnormalities represent state or trait characteristics of depression.

References

  1. Mol Psychiatry. 2008 Sep;13(9):829, 833-57 - PubMed
  2. J Neuropsychiatry Clin Neurosci. 1997 Summer;9(3):471-81 - PubMed
  3. Biol Psychiatry. 2010 Jan 15;67(2):161-7 - PubMed
  4. Psychol Med. 2011 Sep;41(9):1845-55 - PubMed
  5. J Abnorm Psychol. 2007 Feb;116(1):80-5 - PubMed
  6. J Affect Disord. 2011 Nov;134(1-3):272-9 - PubMed
  7. J Affect Disord. 2004 Nov 15;83(1):59-63 - PubMed
  8. Biol Psychiatry. 2002 Jan 1;51(1):59-67 - PubMed
  9. Biol Psychiatry. 2005 Feb 1;57(3):201-9 - PubMed
  10. Neuropsychopharmacology. 2007 Jan;32(1):216-24 - PubMed
  11. Trends Cogn Sci. 1999 Jan;3(1):11-21 - PubMed
  12. Philos Trans R Soc Lond B Biol Sci. 2003 Mar 29;358(1431):561-72 - PubMed
  13. J Abnorm Psychol. 2004 Feb;113(1):121-35 - PubMed
  14. Prog Brain Res. 2006;156:363-78 - PubMed
  15. Biol Psychiatry. 2002 May 1;51(9):693-707 - PubMed
  16. Can J Psychiatry. 2002 May;47(4):327-36 - PubMed
  17. Mol Psychiatry. 2001 Jan;6(1):13-34 - PubMed
  18. J Psychopharmacol. 2010 Aug;24(8):1165-74 - PubMed
  19. Biol Psychiatry. 2010 Mar 1;67(5):414-21 - PubMed
  20. Biol Psychiatry. 2008 May 1;63(9):852-7 - PubMed
  21. J Psychiatr Res. 2007 Sep;41(6):511-22 - PubMed
  22. Trends Cogn Sci. 2000 Jun;4(6):223-233 - PubMed
  23. J Psychiatry Neurosci. 2010 Sep;35(5):311-20 - PubMed
  24. Am J Psychiatry. 2003 Jan;160(1):64-75 - PubMed
  25. Biol Psychiatry. 2001 Nov 1;50(9):651-8 - PubMed
  26. Neuropsychopharmacology. 2008 Jan;33(2):418-24 - PubMed
  27. Biol Psychiatry. 2007 Jan 15;61(2):198-209 - PubMed
  28. Am J Psychiatry. 2007 Apr;164(4):599-607 - PubMed
  29. Neuroimage. 2008 Jun;41(2):544-52 - PubMed
  30. Biol Psychiatry. 2000 Oct 15;48(8):813-29 - PubMed
  31. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):778-85 - PubMed
  32. Neuroimage. 2010 Jan 1;49(1):963-70 - PubMed
  33. Int J Neuropsychopharmacol. 2009 Feb;12(1):11-22 - PubMed
  34. Neuroscience. 2003;118(4):1099-120 - PubMed
  35. Neuropsychopharmacology. 2010 Jan;35(1):192-216 - PubMed
  36. Neuroreport. 2005 Nov 7;16(16):1731-4 - PubMed
  37. Biol Psychiatry. 2005 Sep 15;58(6):495-503 - PubMed
  38. Annu Rev Clin Psychol. 2010;6:285-312 - PubMed
  39. Psychol Med. 2007 Mar;37(3):393-402 - PubMed
  40. Biol Psychiatry. 2012 Feb 15;71(4):286-93 - PubMed
  41. Neuropsychol Rev. 2003 Sep;13(3):113-43 - PubMed
  42. J Affect Disord. 2010 Jan;120(1-3):120-5 - PubMed
  43. Psychol Med. 2010 Mar;40(3):425-32 - PubMed
  44. Arch Gen Psychiatry. 2004 Sep;61(9):877-89 - PubMed
  45. Biol Psychiatry. 2003 Sep 1;54(5):515-28 - PubMed
  46. J Affect Disord. 2011 Apr;130(1-2):66-74 - PubMed
  47. Br Med Bull. 2003;65:193-207 - PubMed
  48. Neuropsychopharmacology. 2006 Aug;31(8):1750-6 - PubMed
  49. Biol Psychiatry. 2008 Sep 15;64(6):505-12 - PubMed
  50. J Psychiatr Res. 2010 Oct;44(14):894-902 - PubMed
  51. Neuron. 2005 Mar 3;45(5):651-60 - PubMed
  52. Biol Psychiatry. 2006 May 1;59(9):816-20 - PubMed
  53. Cogn Emot. 2003 Jan;17(1):101-122 - PubMed
  54. Psychiatry Res. 2007 Jan 15;154(1):13-20 - PubMed
  55. Curr Opin Psychiatry. 2006 Jan;19(1):34-9 - PubMed
  56. Biol Psychol. 2011 Dec;88(2-3):233-42 - PubMed
  57. J Affect Disord. 2011 Apr;130(1-2):127-32 - PubMed
  58. Biol Psychiatry. 2003 Sep 1;54(5):504-14 - PubMed
  59. Psychiatry Res. 2010 Sep 30;183(3):209-17 - PubMed
  60. Neuropsychologia. 2007 Jan 7;45(1):1 - PubMed
  61. J Clin Psychiatry. 2011 Apr;72(4):448-57 - PubMed
  62. Biol Psychiatry. 2004 Mar 15;55(6):578-87 - PubMed
  63. J Abnorm Psychol. 2012 Feb;121(1):61-72 - PubMed
  64. Psychiatry Res. 2009 Aug 30;173(2):158-61 - PubMed
  65. Trends Cogn Sci. 2000 Jun;4(6):215-222 - PubMed
  66. J Affect Disord. 2008 Nov;111(1):13-20 - PubMed
  67. J Nerv Ment Dis. 1999 Oct;187(10):595-602 - PubMed
  68. World J Biol Psychiatry. 2009;10(3):202-8 - PubMed
  69. Br Med Bull. 2003;65:259-70 - PubMed
  70. Neuropsychopharmacology. 2008 Jul;33(8):1909-18 - PubMed
  71. Biol Psychiatry. 2009 Sep 1;66(5):451-9 - PubMed
  72. Am J Psychiatry. 2004 Jul;161(7):1256-63 - PubMed
  73. Neuroimage. 2004 May;22(1):409-18 - PubMed
  74. J Psychiatry Neurosci. 2009 Nov;34(6):418-32 - PubMed
  75. Eur Arch Psychiatry Clin Neurosci. 2006 Jun;256(4):215-21 - PubMed
  76. Genes Brain Behav. 2007 Oct;6(7):672-6 - PubMed
  77. Neuroimage. 2006 May 1;30(4):1441-8 - PubMed
  78. Am J Psychiatry. 2008 Jan;165(1):90-8 - PubMed
  79. Brain. 1995 Feb;118 ( Pt 1):279-306 - PubMed
  80. Curr Opin Neurobiol. 2001 Apr;11(2):240-9 - PubMed
  81. Neuropsychopharmacology. 2011 Jan;36(1):183-206 - PubMed
  82. Neuroimage. 2010 Nov 15;53(3):893-8 - PubMed
  83. PLoS One. 2011 Jan 25;6(1):e15712 - PubMed
  84. Biol Psychiatry. 2010 Jan 15;67(2):155-60 - PubMed
  85. J Am Acad Child Adolesc Psychiatry. 2010 Jan;49(1):42-51 - PubMed
  86. Neuroimage. 2002 Jun;16(2):331-48 - PubMed
  87. Arch Gen Psychiatry. 2010 Nov;67(11):1128-38 - PubMed
  88. Hum Brain Mapp. 2000 Feb;9(2):93-105 - PubMed
  89. J Psychiatry Neurosci. 2007 Nov;32(6):423-9 - PubMed
  90. J Psychosom Res. 2002 Aug;53(2):647-54 - PubMed
  91. Neuroimage. 2007 Jul 1;36(3):736-45 - PubMed
  92. Neuropsychopharmacology. 2011 Jan;36(1):153-82 - PubMed
  93. Psychopharmacology (Berl). 2009 Oct;206(2):197-204 - PubMed
  94. Psychopharmacol Bull. 1992;28(3):261-74 - PubMed
  95. Neuropsychologia. 2007 Jan 7;45(1):174-94 - PubMed
  96. Biol Psychiatry. 2007 Mar 15;61(6):729-30 - PubMed
  97. Nat Rev Neurosci. 2001 May;2(5):352-63 - PubMed
  98. Aust N Z J Psychiatry. 2010 Aug;44(8):681-96 - PubMed
  99. Psychiatry Res. 2006 Jun 30;143(1):63-75 - PubMed
  100. Annu Rev Clin Psychol. 2005;1:167-95 - PubMed

Publication Types